Feeds:
Posts
Comments

Archive for March 8th, 2021

 

Successful ‘Date-Certain M&A’ of Ravenna Pharmaceuticals, Inc., additional Intellectual Property assets

Gerbsman Partners is pleased to announce the successful completion of maximizing the value of additional intellectual properties at Ravenna Pharmaceuticals, Inc.

Due to market conditions and trends, the Board of Directors made the strategic decision to maximize the value of its intellectual properties.

Gerbsman Partners – led by Steven R. Gerbsman, Principal and Kenneth Hardesty (CEO in Residence)– provided the Board of Directors with financial advisory leadership through its proprietary ‘Date-Certain M&A Process’,facilitated the sale of the company’s Intellectual Property and the closing of the sale.

Specifically, Gerbsman Partners provided leadership with:

  1. Business consulting and investment banking domain expertise in developing strategic action plans.
  1. Implementing its proprietary ‘Date-Certain M&A Process’ in order to maximize value of Ravenna Pharmaceuticals intellectual properties.
  2. “Managing and guiding the process” among potential acquirers, lawyers, advisors, as well as all stakeholders of interest.

About Gerbsman Partners

Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in underperforming, undercapitalized and undervalued companies and their intellectual properties. Since 2001, Gerbsman Partners has successfully maximized the values of 112 companies in a wide and diverse spectrum of industries, ranging from technology, medical device/life science, digital marketing to cyber security, to name only a few.*

In the process, GP has successfully restructured/terminated over $810 million of real estate executory contracts and equipment lease/sub-debt obligations, and has assisted in over $2.3 billion of financings, restructurings and M&A transactions.*

Gerbsman Partners has offices and strategic alliances in San Francisco, Orange County, Boston, New York, Washington DC, McLean, VA, Europe and Israel.

*For further information on Gerbsman Partners expertise and industry experience, please request our company profile here

 

Read Full Post »